NCT00093782 2017-02-07Temsirolimus in Treating Patients With Metastatic Neuroendocrine CarcinomaNational Cancer Institute (NCI)Phase 2 Completed36 enrolled 12 charts
NCT00131911 2014-11-17Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine TumorsNational Cancer Institute (NCI)Phase 2 Completed93 enrolled 10 charts